Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature

A Oeconomou, H Madersbacher, G Kiss, TJ Berger… - European urology, 2008 - Elsevier
CONTEXT: The intraprostatic injection of botulinum neurotoxin type A (BoNT-A) is a
minimally invasive but still-experimental treatment of lower urinary tract symptoms (LUTS) …

Injection therapy for prostatic disease: A renaissance concept

AM Saemi, JB Folsom, MK Plante - Indian Journal of Urology, 2008 - journals.lww.com
Purpose: Initially conceived as an intervention for prostatic infection, injection therapy has
been used to alleviate urinary retention, and is now primarily investigated for the treatment of …

Injectables in the prostate

AM Saemi, MK Plante - Current opinion in urology, 2008 - journals.lww.com
Injection therapy remains a very promising minimally invasive surgical therapy for benign
prostatic hyperplasia with increased attention from the urologic community in recent years …

[PDF][PDF] Image-Guided Ablation of Painful Osteolyses

DT Wang, CE Ray Jr - Pain Management in Interventional …, 2008 - ndl.ethernet.edu.et
In the past, strategies for the mitigation of tumor pain have been limited to surgery,
radiotherapy, or pharmacotherapy. Unfortunately, in many cases, these strategies fail …

Prostatta enjekte edilebilen ajanlarla tedaviler

AM Saemi, MK Plante - Current Opinion in Urology, 2008 - turkiyeklinikleri.com
Injection therapy remains a very promising minimally invasive surgical therapy for benign
prostatic hyperplasia with increased attention from the urologic community in recent years …

[引用][C] Ботулинический токсин типа А в лечении больных аденомой и раком простаты

ЕБ Мазо, ГГ Кривобородов, МЕ Школьников… - Урология, 2008 - elibrary.ru